Source:http://linkedlifedata.com/resource/pubmed/id/19115315
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-1-27
|
pubmed:abstractText |
AP-2 is a transcription factor implicated in mammalian development, cell proliferation, apoptosis, and carcinogenesis. To identify potential AP-2alpha-interacting partners, a yeast two-hybrid screen was performed in human brain cDNA library. One of the identified clones encodes potassium channel tetramerization domain-containing 1 (KCTD1). We demonstrated the novel KCTD1-AP-2alpha interaction in vitro by GST pull-down assays and in vivo by co-immunoprecipitation assays and mapped the interaction domains to the N-termini of both proteins. In addition, we observed that the two proteins were completely co-localized in the nuclei of mammalian cells. Transient transfection assays using four promoters containing AP-2-binding sites confirmed that KCTD1 significantly repressed AP-2alpha-mediated transactivation through the BTB domain, whereas KCTD1 siRNA strongly relieved KCTD1-mediated repression of AP-2alpha transcriptional activity, and other BTB domain proteins such as PDIP1, KCTD10, and TNFAIP1 did not markedly inhibit the transcriptional activity of AP-2alpha, suggesting that KCTD1 specifically acts as a negative regulator of AP-2alpha. Finally, we found that KCTD1 interacted with three major members of the AP-2 family and inhibited their transcriptional activities. Taken together, our results indicate the novel function of KCTD1 as the transcriptional repressor for AP-2 family, especially for AP-2alpha.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1097-4644
|
pubmed:author |
pubmed-author:DingXiaofengX,
pubmed-author:GanLuL,
pubmed-author:GaoXiangX,
pubmed-author:HeAilanA,
pubmed-author:HuXiangX,
pubmed-author:LuoChangC,
pubmed-author:RenKaiqunK,
pubmed-author:ZhangJianJ,
pubmed-author:ZhongYingliY,
pubmed-author:ZhouFangliangF,
pubmed-author:ZhouJianlinJ,
pubmed-author:ZhuJiaolianJ
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
285-95
|
pubmed:meshHeading |
pubmed-meshheading:19115315-Cell Line,
pubmed-meshheading:19115315-Gene Expression Regulation,
pubmed-meshheading:19115315-Humans,
pubmed-meshheading:19115315-Protein Binding,
pubmed-meshheading:19115315-Repressor Proteins,
pubmed-meshheading:19115315-Substrate Specificity,
pubmed-meshheading:19115315-Transcription Factor AP-2,
pubmed-meshheading:19115315-Transcriptional Activation
|
pubmed:year |
2009
|
pubmed:articleTitle |
The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation.
|
pubmed:affiliation |
Model Animal Research Center, Nanjing University, Nanjing 210089, PR China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|